These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15526160)

  • 1. Signal transduction via the stem cell factor receptor/c-Kit.
    Rönnstrand L
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2535-48. PubMed ID: 15526160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1307-15. PubMed ID: 16226710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
    Pedersen M; Rönnstrand L; Sun J
    Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA; Hu J; Stein PL; Craig AW
    Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analyses of the kit receptor for the steel factor.
    Blechman JM; Lev S; Givol D; Yarden Y
    Stem Cells; 1993 Jul; 11 Suppl 2():12-21. PubMed ID: 7691317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
    Ali S; Ali S
    Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.
    Yuzawa S; Opatowsky Y; Zhang Z; Mandiyan V; Lax I; Schlessinger J
    Cell; 2007 Jul; 130(2):323-34. PubMed ID: 17662946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal and oncogenic forms of the receptor tyrosine kinase kit.
    Lennartsson J; Jelacic T; Linnekin D; Shivakrupa R
    Stem Cells; 2005; 23(1):16-43. PubMed ID: 15625120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new twist in the transmembrane signaling tool-kit.
    Lemmon MA; Ferguson KM
    Cell; 2007 Jul; 130(2):213-5. PubMed ID: 17662934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction by several KIT juxtamembrane domain mutations.
    Casteran N; De Sepulveda P; Beslu N; Aoubala M; Letard S; Lecocq E; Rottapel R; Dubreuil P
    Oncogene; 2003 Jul; 22(30):4710-22. PubMed ID: 12879016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of murine STAP-1, the stem-cell-specific adaptor protein containing PH and SH2 domains.
    Masuhara M; Nagao K; Nishikawa M; Sasaki M; Yoshimura A; Osawa M
    Biochem Biophys Res Commun; 2000 Feb; 268(3):697-703. PubMed ID: 10679268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor.
    Hassel S; Yakymovych M; Hellman U; Rönnstrand L; Knaus P; Souchelnytskyi S
    J Cell Physiol; 2006 Feb; 206(2):457-67. PubMed ID: 16155937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R; Bernstein A; Watring N; Linnekin D
    Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma.
    Plo I; Lautier D; Casteran N; Dubreuil P; Arock M; Laurent G
    Oncogene; 2001 Oct; 20(46):6752-63. PubMed ID: 11709710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kit as a human oncogenic tyrosine kinase.
    Kitamura Y; Hirotab S
    Cell Mol Life Sci; 2004 Dec; 61(23):2924-31. PubMed ID: 15583854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of Kit in disease and the application of pharmacogenetics.
    Akin C; Metcalfe DD
    J Allergy Clin Immunol; 2004 Jul; 114(1):13-9; quiz 20. PubMed ID: 15241338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit.
    Wollberg P; Lennartsson J; Gottfridsson E; Yoshimura A; Rönnstrand L
    Biochem J; 2003 Mar; 370(Pt 3):1033-8. PubMed ID: 12444928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts.
    Caruana G; Cambareri AC; Ashman LK
    Oncogene; 1999 Sep; 18(40):5573-81. PubMed ID: 10523834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.